Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib

Lignende værker

• PD-1(+) and Foxp3(+) T cell reduction correlates with survival of HCC patients after sorafenib therapy
  af: Kalathil, Suresh Gopi, et al.
  Udgivet: (2016)
• High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
  af: Lugade, Amit A, et al.
  Udgivet: (2013)
• Higher frequencies of GARP+ CTLA-4+ Foxp3+ T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T cell functionality
  af: Kalathil, Suresh, et al.
  Udgivet: (2013)
• Augmentation of IFN-γ(+) CD8(+) T cell responses correlates with survival of HCC patients on sorafenib therapy
  af: Kalathil, Suresh Gopi, et al.
  Udgivet: (2019)
• T-Regulatory Cells and Programmed Death 1(+) T Cells Contribute to Effector T-Cell Dysfunction in Patients with Chronic Obstructive Pulmonary Disease
  af: Kalathil, Suresh Gopi, et al.
  Udgivet: (2014)